Alex Carchidi, expert in dissecting the biotech sector, discusses the importance of diversification and the challenges faced in the industry. Topics include gene editing, gene therapy, the impact of high drug prices, and the risks and rewards of investing in biotechs. Attention is also given to the future of the US healthcare system and the focus on treating rather than curing diseases in the pharmaceutical industry.